Abstract
In the pharmaceutical industry, each and every activity is done according to standard operating procedures and protocols. Standard operating procedures are the pre-established stepwise instructions to carry out routine operations while protocols are predefined written document used for design and execution of experiments. In the current scenario, pharmaceutical industry wants to manufacture quality product as per good manufacturing practice guidelines. To achieve six sigma qualities, deviations are very important to consider. Deviations have to be addressed, investigated, and based on investigation data, suitable corrective actions and preventive actions are applied for prevention of its reoccurrence. Corrective actions and preventive actions are important part of quality management system. Corrective actions and preventive actions is a system which falls under good manufacturing practice and many International Standard Organization business standards. Corrective actions and preventive actions include route cause analysis for resolving deviation, which includes its cause of identification, and helps to prevent its occurrence in future. Corrective actions and preventive actions is a combination of ideas and tools to correct deviation. Inappropriate initial route cause identification and application of corrective actions and preventive actions lead to extra work, time, and cost. There are some exceptional cases in which corrective actions and preventive actions are not required, for instance one-time deviation, where only corrective actions are done. The corrective actions and preventive actions system improves and maintains processes, procedures, organization, and business in a systematic, organized, well-documented, and actionable way. In this article, case studies of deviations in pharmaceutical industry helped in identification and evaluation of deviation and based on that application, suitable corrective actions and preventive actions are shown which give thorough understanding of deviation and application of corrective actions and preventive actions in pharmaceutical industry. So, corrective actions and preventive actions are not only regulatory requirements but they make good business sense to the pharmaceutical industry.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.